申请人:Merck Sharp & Dohme Ltd.
公开号:US05580877A1
公开(公告)日:1996-12-03
A class of 3,5-dihydro-1H-pyrazolo[3,4-c]quinoline-1,4(2H)-dione derivatives, substituted in the 2-position by an optionally substituted phenyl moiety, are selective non-competitive antagonists of NMDA receptors and/or are antagonists of AMPA receptors, and are therefore of utility in the treatment and/or prevention of conditions, such as neurodegenerative disorders, convulsions or schizophrenia, which require the administration of an NMDA and/or AMPA antagonist.
一类3,5-二氢-1H-吡唑并[3,4-c]喹啉-1,4(2H)-二酮衍生物,其2-位取代为可选取代的苯基基团,是选择性非竞争性NMDA受体拮抗剂和/或AMPA受体拮抗剂,因此在治疗和/或预防需要使用NMDA和/或AMPA拮抗剂的情况下,如神经退行性疾病、惊厥或精神分裂症等方面具有实用价值。